A multicenter, open-label, phase 2 study of lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: the MM-021 trial

被引：0
作者：
Jian Hou
Xin Du
Jie Jin
Zhen Cai
Fangping Chen
Dao-bin Zhou
Li Yu
Xiaoyan Ke
Xiao Li
Depei Wu
Fanyi Meng
Huisheng Ai
Jingshan Zhang
Honeylet Wortman-Vayn
Nianhang Chen
Jay Mei
Jianmin Wang
机构：
[1] Shanghai Changzheng Hospital,Department of Hematology
[2] Guangdong General Hospital,The 1st Hospital
[3] Zhejiang University,undefined
[4] Xiangya Hospital of Central South University,undefined
[5] Peking Union Medical College Hospital,undefined
[6] The 301 Hospital-Chinese PLA General Hospital,undefined
[7] Peking University Third Hospital,undefined
[8] Shanghai 6th Hospital,undefined
[9] The 1st Affiliated Hospital of Soochow University,undefined
[10] Nanfang Hospital of Southern Medicine University in Guangzhou,undefined
[11] The 307 PLA Hospital,undefined
[12] Celgene Corporation,undefined
[13] Changhai Hospital,undefined
来源：
Journal of Hematology & Oncology | / 6卷
关键词：
Relapsed/Refractory Multiple Myeloma; Chinese Patients; Lenalidomide; Low-dose Dexamethasone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 364 条
[51]  
Lonial S(undefined)undefined undefined undefined undefined-undefined
[52]  
Yu Z(undefined)undefined undefined undefined undefined-undefined
[53]  
Patin J(undefined)undefined undefined undefined undefined-undefined
[54]  
Olesnyckyj M(undefined)undefined undefined undefined undefined-undefined
[55]  
Zeldis JB(undefined)undefined undefined undefined undefined-undefined
[56]  
Knight RD(undefined)undefined undefined undefined undefined-undefined
[57]  
Iida S(undefined)undefined undefined undefined undefined-undefined
[58]  
Chou T(undefined)undefined undefined undefined undefined-undefined
[59]  
Okamoto S(undefined)undefined undefined undefined undefined-undefined
[60]  
Nagai H(undefined)undefined undefined undefined undefined-undefined
12345678910